RT Journal Article
SR Electronic
T1 Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001636
DO 10.1136/jitc-2020-001636
VO 9
IS 2
A1 Pierini, Stefano
A1 Mishra, Abhishek
A1 Perales-Linares, Renzo
A1 Uribe-Herranz, Mireia
A1 Beghi, Silvia
A1 Giglio, Andrea
A1 Pustylnikov, Sergei
A1 Costabile, Francesca
A1 Rafail, Stavros
A1 Amici, Augusto
A1 Facciponte, John G
A1 Koumenis, Costantinos
A1 Facciabene, Andrea
YR 2021
UL http://jitc.bmj.com/content/9/2/e001636.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.